Page 279 - Eshre Final Programme 2015
P. 279
P-700 Ovarian reserve and IVF outcome in different ethnic groups
J. Grace1, S. Ghosh1, M. Allan2, S. Dyson3, J. Kopeika1
1Guy's and St Thomas', Assisted Conception Unit, London, United Kingdom 2Kingston Hospital, O and G, London, United Kingdom
3Kings College London, Medical school, London, United Kingdom
P-701 Androgen synthesis in peripheral adipose tissue: the role of insulin and luteinizing hormone in women with polycystic ovarian syndrome
N. Azanati1, R. Khan1, S. Amer1
1University of Nottingham, Gynaecology&obstetric, Nottingham, United Kingdom
P-702 The connections between serum Anti-Mullerian hormone and metabolic parameters in polycystic ovary syndrome patients vary depending on body mass index category
A. Albu1, D. Albu2, S. Radian1, S. Florea3, S. Fica1
1UMF Carol Davila, Endocrinology, Bucharest, Romania
2UMF Carol Davila, Obstetric Gynecology, Bucharest, Romania 3Elias Hospital, Laboratory, Bucharest, Romania
P-703 Identification of altered serum metabolites in women with PCOS using gas chromatography-mass spectrometry (GC-MS)
S. RoyChoudhury1, T.H. More2, J. Christie2, B.P. Mishra1, R. Chattopadhyay3, I. Lodh3, C. DattaRay4, G. Bose3, H.S. Sarkar3, B.N. Chakravarty3, S. Rapole2, K. Chaudhury1
1Indian Institute of Technology Kharagpur, School of Medical Science and Technology, Kharagpur, India
2National Centre for Cell Science, Proteomics Lab, Pune, India
3Institute of Reproductive Medicine, Infertility and ART clinic, Kolkata, India
4Institute of Post Graduate Medical Education & Research, Department of Obstetrics and Gynecology, Kolkata, India
P-704 Effect of testosterone administration on ovarian morphology, determined by transvaginal (3D) ultrasound in female-to-male transsexuals.
M.R. Caanen1, N.E. Schouten1, E.A. Kuijper1, A. Overbeek1, M.H. Van den Berg2,
E. Van Dulmen-den Broeder2, F.E. Van Leeuwen3, M.A. Van Trotsenbrug1, C.B. Lambalk1
1VU University Medical Center, Obstetrics and Gynaecology, Amsterdam, The Netherlands 2VU University Medical Center, Pediatric Oncology-Hematology, Amsterdam, The Netherlands 3Netherlands Cancer Institute, Epidemiology, Amsterdam, The Netherlands
FINAL PROGRAMME I LISBON, PORTUGAL – 14 TO 17 JUNE 2015 279
POSTERS